Literature DB >> 15082074

A study of vehicles for dosing rodent whole embryo culture with non aqueous soluble compounds.

Karen A Augustine-Rauch1, Qin Zhang, Mark Kleinman, Richard Lawton, Michael J Welsh.   

Abstract

In rodent whole embryo culture (WEC), finding vehicles for non-aqueous-soluble compounds has been problematic due to developmental toxicity associated with many solvents. The purpose of this study was to identify alternative vehicles for insoluble compounds. In WEC, we evaluated carrier solutions containing bovine serum albumin (BSA) and glycerol as well as the solvents, formamide, dimethylformamide (DMF), dimethyl sulfoxide (DMSO) and ethanol, for relative teratogenicity and delivery of the insoluble teratogen, all-trans retinoic acid (RA). At a concentration of <or=0.04%, formamide and DMF exhibited no significant toxicity to cultured rat embryos and were effective at delivering RA to the embryo. The BSA and glycerol carrier solutions were not teratogenic, although both inhibited robust formation of yolk sac vasculature. Both solutions delivered RA to the cultured rat embryos at higher doses. In summary, all four solvents/solutions may have utility as vehicles dependent upon the chemical properties of the compound to be solubilized.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082074     DOI: 10.1016/j.reprotox.2004.01.006

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  2 in total

1.  Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β.

Authors:  Hexiao Tang; Yongde Liao; Guang Chen; Liqiang Xu; Chao Zhang; Sheng Ju; Sheng Zhou
Journal:  Med Oncol       Date:  2012-03-17       Impact factor: 3.064

2.  High loading of trimethylglycine promotes aqueous solubility of poorly water-soluble cisplatin.

Authors:  Riki Kadokawa; Tetsuo Fujie; Gyanendra Sharma; Kojiro Ishibashi; Kazuaki Ninomiya; Kenji Takahashi; Eishu Hirata; Kosuke Kuroda
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.